GlassScriptPhysician profile
Edgar M Conrad
NPI 1124055074
$1,860.14
in general payments reported to CMS, 2019-2025
13 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $341 · 2021: $150 · 2022: $24.55 · 2023: $261 · 2024: $586 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $482.47 | 2019-2024 | Breztri, Airsupra, Farxiga |
| Neurocrine Biosciences, INC. | $258.82 | 2024-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $142.71 | 2024-2025 | Rexulti |
| Novo Nordisk INC | $138.02 | 2019-2022 | |
| Dexcom, INC. | $126.57 | 2023 | Dexcom G7 Gss (161) |
| Axsome Therapeutics, INC. | $124.63 | 2025 | Auvelity |
| Amgen INC. | $118.60 | 2020 | |
| Alkermes, INC. | $116.07 | 2024 | Lybalvi |
| Bayer Healthcare Pharmaceuticals INC. | $112.33 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $107.84 | 2023 | Austedo Xr |
| Pfizer INC. | $93.99 | 2020 | |
| Nestle Healthcare Nutrition INC. | $25.60 | 2021 | |
| Amarin Pharma, INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.